NASDAQ · Health care

CDT Equity Inc. (CDT)

It posted a net loss of $37.1M. At June 30, 2026 it held $747K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Price

$0.08

-33.88% on the day · September 25, 2026

52-week range $0.08 to $1,778.00

Market cap

$62.9K

What CDT Equity Inc. does

CDT Equity Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CDT.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$36.8M	-$39.2M	-$1,177.89	n/a
2024	n/a	-$15.4M	-$17.8M	-$61,598.62	-$9.7M
2023	n/a	-$5.3M	-$535K	-$26,763.75	n/a
2022	n/a	-$3.2M	-$4.9M	-$38,658.74	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around October 12, 2026.

Estimated from its filing rhythm: about 60 days after its last report of August 12, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What CDT Equity Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 25, 2026
Shareholder rights changed 8-K
September 18, 2026
Securities offering prospectus 424B3
September 18, 2026
Material agreement 8-K
September 18, 2026
Securities offering prospectus 424B3
September 9, 2026
Passive stake (5% or more) SCHEDULE 13G
September 8, 2026
IPO registration S-1
September 4, 2026
Material agreement 8-K
September 2, 2026
Passive stake (5% or more) SCHEDULE 13G
September 2, 2026
Activist stake changed SCHEDULE 13D/A
September 1, 2026
Other event 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 2, 2026. Insider transactions on SEC

Insider trades

What the people running CDT Equity Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $0 worth of shares in the last 90 days and bought none on the open market.

Bought (open market)

last 90 days

Sold

last 90 days

Net sold

290

Date	Insider	What	Shares	Price	Value	Filing
August 28, 2026	Regan AndrewChief Executive Officer, Director	Other changeindirect	5,436,830	-	-	Form 4
August 28, 2026	Regan AndrewChief Executive Officer, Director	Soldindirect	290	-	-	Form 4
June 18, 2026	Taylor Mark Andrew10% owner	Soldindirect	5,000	$0.71	$3.5K	Form 4
June 18, 2026	Taylor Mark Andrew10% owner	Soldindirect	1,464,711	$1.44	$2.1M	Form 4
June 18, 2026	Taylor Mark Andrew10% owner	Soldindirect	5,000	$0.75	$3.8K	Form 4
June 18, 2026	Taylor Mark Andrew10% owner	Soldindirect	593,289	$1.40	$829.1K	Form 4
May 13, 2026	Regan AndrewChief Executive Officer, Director	Received as payindirect	100,000	$1.90	$190K	Form 4
March 24, 2026	Regan AndrewChief Executive Officer, Director	Received as payindirect	147,401	-	-	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CDT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Andrew Regan13D, may seek influence with 1 related filers	43.7%	5,699,306	September 2, 2026
Ascent Partners Fund LLC13G, passive with 9 related filers	9.9%	543,645	June 5, 2026
Taylor Mark Andrew13G, passive with 2 related filers	9.6%	1,258,042	September 2, 2026
Wigglesworth Craig Stuart13G, passive	9.6%	1,258,042	September 9, 2026

Latest filings below 5%: Primary Development Fund (Cayman) SPC 2.97% (August 21, 2026); Nirland Limited 1.6% (May 20, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 5,692,933 shares in total, about $455.4K at the last price.

Holder	Shares	As of
Regan AndrewChief Executive Officer, Director	5,692,9335,692,933 held indirectly	August 28, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CDT

What does CDT Equity Inc. do?

CDT Equity Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CDT.

Is CDT Equity Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $37.1M.

When did CDT Equity Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shareholder rights changed from September 25, 2026.

Similar companies

Compare CDT with

Compare CDT with any company

Follow CDT

Get an email when CDT Equity Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CDT: get an email when it files

Where the numbers come from

Financial figures are the values CDT Equity Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.